A&G Pharmaceutical, Inc. Receives $300,000 Research Grant From Avon Foundation at 11th Annual Avon Walk for Breast Cancer, Washington DC
5/7/2013 9:53:14 AM
More...
|
Mayo Clinic's Mayo Medical Laboratories Signs Agreement With A&G Pharmaceutical, Inc.
3/6/2012 11:26:31 AM
More...
|
A&G Pharmaceutical, Inc. Awarded Phase II SBIR Grant for Development of GP88 Drug Candidate Targeted to Breast Cancer
9/28/2010 9:53:05 AM
More...
|
A&G Pharmaceutical, Inc. Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
12/14/2007 7:55:27 AM
More...
|
A&G Pharmaceutical, Inc. And Celltrion, Inc. Announce Bioprocess Development & Manufacturing Agreement For A&G Anti-GP88 Cancer Therapeutic Antibody - Deal Worth Up To $8.4 Million
6/7/2006 10:45:33 AM
More...
|
Tech Council of Maryland Release: Area Life Science Companies Chosen To Make Presentations For Venture Funding At 2005 Mid-Atlantic Bio
10/19/2005 5:13:20 PM
More...
|
ASM Resources, Inc. Announces Investments In Four Early-Stage Companies; A&G Pharmaceutical, Inc., Claragen, Inc., Marligen Biosciences, Inc.
10/19/2005 5:10:56 PM
More...
|
A&G Pharmaceutical, Inc. Completes $750,000 Private Financing
10/19/2005 5:10:35 PM
More...
|
A&G Pharmaceutical, Inc. Completes Series A Financing
10/19/2005 5:09:15 PM
More...
|